Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy

James Crespo, Hongxia Sun, Jimin Wu, Qing Qing Ding, Guilin Tang, Melissa K. Robinson, Hui Chen, Aysegul A. Sahin, Bora Lim

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Chemistry